Nanterinone is a novel positive inotropic and balanced-type vasodilating drug, only partially based on phosphodiesterase III inhibition. Nanterinone exhibits acute hemodynamic effects in patients with mild to moderate heart failure. References: Remme WJ, van der Ent M, Bartels GL, van Schelven D, van Hoogenhuyze DC, Krauss XH, Kruijssen HA, Storm CJ. Acute hemodynamic effects and preload-dependent cardiovascular profile of the partial phosphodiesterase inhibitor nanterinone in patients with mild to moderate heart failure. Cardiovasc Drugs Ther. 1996 May;10(2):137-44. PubMed PMID: 8842505.

纯度：≥98%

CAS：102791-47-9